ArticleCell death & disease2026

Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.

Mingjun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.